These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4654583)

  • 21. Contributions of nitrosoureas to cancer treatment.
    Mitchell EP; Schein PS
    Cancer Treat Rep; 1986 Jan; 70(1):31-41. PubMed ID: 3002621
    [No Abstract]   [Full Text] [Related]  

  • 22. [Cellular mechanism of the antileukemic action of quinoline dibromide].
    Golenko OD; Paramonova TD; Nikolaeva TG
    Biull Eksp Biol Med; 1984 Jul; 98(7):59-61. PubMed ID: 6466833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of 1,3-bis(2-chloroethyl)-1-nitrosourea and related compounds upon the synthesis of DNA by cell-free systems.
    Wheeler GP; Bowdon BJ
    Cancer Res; 1968 Jan; 28(1):52-9. PubMed ID: 5635372
    [No Abstract]   [Full Text] [Related]  

  • 24. DNA damage and repair in mouse leukemia L1210 cells treated with nitrogen mustard, 1,3-bis(2-chloroethyl)-1-nitrosourea, and other nitrosoureas.
    Ewig RA; Kohn KW
    Cancer Res; 1977 Jul; 37(7 Pt 1):2114-22. PubMed ID: 558823
    [No Abstract]   [Full Text] [Related]  

  • 25. L1210 leukemia i.v. implanted as a model for testing short-chain nitrosourea analogs.
    Schmid JR; Fiebig HH; Eisenbrand G; Löhr GW
    J Cancer Res Clin Oncol; 1986; 111(1):31-4. PubMed ID: 3949848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 3-(Tetraacetyl glucopyranos-2-yl)-1-(2-chloroethyl)-1-nitrosourea, an antitumor agent with modified bone marrow toxicity.
    Schein PS; McMenamin MG; Anderson T
    Cancer Res; 1973 Sep; 33(9):2005-9. PubMed ID: 4353476
    [No Abstract]   [Full Text] [Related]  

  • 27. Tumor chemotherapy: efficacy dependent on mode of growth.
    Hagemann RF; Schenken LL; Lesher S
    J Natl Cancer Inst; 1973 Feb; 50(2):467-74. PubMed ID: 4633910
    [No Abstract]   [Full Text] [Related]  

  • 28. Increased immunogenicity of murine lymphatic tumors by pyrazole-4-carboxamide, 3(or 5)-amino (NSC-1402; PCA).
    Nicolin A; Vadlamudi S; Goldin A
    Cancer Chemother Rep; 1973 Feb; 57(1):3-10. PubMed ID: 4704101
    [No Abstract]   [Full Text] [Related]  

  • 29. The thymidine-14C and -3H double-labeling technic in the study of the cell cycle of L1210 leukemia ascites tumor in vivo.
    Young RC; DeVita VT; Perry S
    Cancer Res; 1969 Aug; 29(8):1581-4. PubMed ID: 5807231
    [No Abstract]   [Full Text] [Related]  

  • 30. Age-specific changes in the proliferation of Ehrlich ascites tumor cells grown as solid tumors.
    Lala PK
    Cancer Res; 1972 Mar; 32(3):628-36. PubMed ID: 5061312
    [No Abstract]   [Full Text] [Related]  

  • 31. Synthesis and activities of antitumor agents.
    Suami T; Machinami T; Hisamatsu T
    J Med Chem; 1979 Mar; 22(3):247-50. PubMed ID: 423206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Kinetic study of the effect of N-nitroso-N-alkylurea on the development of leukemia L1210].
    Ostrovskaia LA; Sokolova IS; Gorbacheva LB
    Vopr Onkol; 1977; 23(3):59-63. PubMed ID: 898797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Value of cytosine arabinoside (NSC-63878) plus 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) therapy in advanced murine L1210 leukemia and enhancement of the combination with sequential doses of methotrexate (NSC-740) or 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962).
    Kline I; Woodman RJ; Gang M; Cysyk RL; Venditti JM
    Cancer Chemother Rep; 1973; 57(3):291-8. PubMed ID: 4751255
    [No Abstract]   [Full Text] [Related]  

  • 34. Antileukemic properties of dichloro(1,2-diaminocyclohexane)platinum(II).
    Gale GR; Walker EM; Atkins LM; Smith AB; Meischen SJ
    Res Commun Chem Pathol Pharmacol; 1974 Mar; 7(3):529-38. PubMed ID: 4824827
    [No Abstract]   [Full Text] [Related]  

  • 35. Analysis of variations in the cell population kinetics with tumor age in the L1210 ascites tumor.
    Dombernowsky P; Hartmann NR
    Cancer Res; 1972 Nov; 32(11):2452-8. PubMed ID: 5082593
    [No Abstract]   [Full Text] [Related]  

  • 36. Synthesis of nitrosourea derivatives of sucrose as central nervous system anticancer agents.
    Almquist RG; Reist EJ
    J Med Chem; 1977 Oct; 20(10):1246-50. PubMed ID: 903916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of nitrosomethylurea (NMU) on the growth kinetics and protein biosynthesis in leukemia L1210 cells].
    Kukushkina GV; Sokolova IS; Ostrovskaia LA; Gorbacheva LB
    Izv Akad Nauk SSSR Biol; 1972; 5():731-6. PubMed ID: 4667390
    [No Abstract]   [Full Text] [Related]  

  • 38. Chemotherapy and the life cycle of leukaemic cells. A comparison between the growth characteristics of human acute leukaemia and the murine leukaemia L 1210.
    Benckhuijsen C
    Folia Med Neerl; 1969 Dec; 12(2):74-84. PubMed ID: 4894168
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of the experimental antitumor activities of three nitrosourea derivatives chlorozotocin, RFCNU and CNCC encapsulated in liposomes with those in the free state.
    Maral R; Bourut C; Chenu E; Mathe G; Bernon R; Lussan C; Imbach JL; Schein P; Bothorel P
    Oncology; 1985; 42(2):122-8. PubMed ID: 3157909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytokinetic studies of the regenerative phase in the JB-1 ascites tumour.
    Dombernowsky P; Bichel P; Hartmann NR
    Cell Tissue Kinet; 1974 Jan; 7(1):47-60. PubMed ID: 4810550
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.